Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for PEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 39.39M
March 31, 2026 39.32M
December 31, 2025 39.23M
September 30, 2025 39.15M
June 30, 2025 38.97M
March 31, 2025 38.68M
December 31, 2024 38.49M
September 30, 2024 38.36M
June 30, 2024 38.84M
March 31, 2024 38.76M
December 31, 2023 38.68M
September 30, 2023 38.57M
June 30, 2023 38.41M
March 31, 2023 38.24M
December 31, 2022 38.11M
September 30, 2022 37.97M
June 30, 2022 37.88M
March 31, 2022 37.67M
December 31, 2021 37.58M
September 30, 2021 36.67M
June 30, 2021 36.57M
March 31, 2021 36.48M
December 31, 2020 36.41M
September 30, 2020 36.30M
Date Value
June 30, 2020 36.04M
March 31, 2020 35.07M
December 31, 2019 35.00M
September 30, 2019 34.91M
June 30, 2019 34.79M
March 31, 2019 34.56M
December 31, 2018 34.44M
September 30, 2018 34.50M
June 30, 2018 34.38M
March 31, 2018 34.26M
December 31, 2017 33.69M
September 30, 2017 33.94M
June 30, 2017 33.77M
March 31, 2017 33.63M
December 31, 2016 31.11M
September 30, 2016 31.64M
June 30, 2016 31.05M
March 31, 2016 30.70M
December 31, 2015 29.90M
September 30, 2015 29.88M
June 30, 2015 30.64M
March 31, 2015 24.43M
June 30, 2014 30.64M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp. 1.447B
Globus Medical, Inc. 134.25M
Teleflex, Inc. 42.37M
Abbott Laboratories 1.730B
AngioDynamics, Inc. 41.70M